Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm
This study has been completed.
Study NCT00964730   Information provided by Teva Pharmaceutical Industries

First Received on August 21, 2009.   Last Updated on April 6, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Talampanel
Moxifloxacin
Placebo
Additional drug interventions recognized in this trial
Norgestimate, ethinyl estradiol drug combination
More general drug interventions related to this trial
Anti-Infective Agents
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Teva Pharmaceutical Industries
Cetero Research, San Antonio


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services